1. Bossuyt X, Cohen Tervaert J‑W, Arimura Y et al (2017) Position paper: revised 2017 international
consensus on testing of ANCas in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev
Rheumatol.
https://doi.org/10.1038/nrrheum.2017.140
2. ClinicalTrials.gov Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener’s);
https://www.clinicaltrials.gov/ct2/show/NCT02108860?cond=abatacept+ANCA&rank=2
. Zugegriffen: 25.08.2017
3. ClinicalTrials.gov Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis (MAINRITSAN 2);
https://clinicaltrials.gov/ct2/show/NCT01731561?cond=rituximab+anca&draw=1&rank=5
. Zugegriffen: 10.09.2017
4. ClinicalTrials.gov Comparison Between a Long Term and a Conventional Maintenance Treatment With Rituximab (MAINRITSAN3);
https://clinicaltrials.gov/ct2/show/NCT02433522?cond=rituximab+anca&draw=1&rank=3
. Zugegriffen: 10.09.2017
5. ClinicalTrials.gov Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis (MYCYC);
https://www.clinicaltrials.gov/ct2/show/NCT00414128?cond=mycophenolate+ANCA&rank=3
. Zugegriffen: 25.08.2017